Last reviewed · How we verify
IBC0966
At a glance
| Generic name | IBC0966 |
|---|---|
| Sponsor | SUNHO（China）BioPharmaceutical CO., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IBC0966 CI brief — competitive landscape report
- IBC0966 updates RSS · CI watch RSS
- SUNHO（China）BioPharmaceutical CO., Ltd. portfolio CI